ALVIN KINGCADE: Open Payments
NPI 1881711125 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,969 in 85 payments from 9 companies in 2025. Trend: 2023 $12,937 · 2024 $11,147 · 2025 $21,969
Speaker / faculty: $15,965Food & beverage: $4,021Travel & lodging: $1,983
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 42 | $19,658 |
| ViiV Healthcare Company | 25 | $1,090 |
| AstraZeneca Pharmaceuticals LP | 6 | $577 |
| ABBVIE INC. | 6 | $300 |
| Lilly USA, LLC | 2 | $171 |
| EMD Serono, Inc. | 1 | $109 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Theratechnologies Inc. | 1 | $17 |
Products named: Descovy, Biktarvy, Yeztugo, TEZSPIRE, DOVATO, MAVYRET, CABENUVA, Veklury.
Industry payments across NJ — which companies pay providers there.
